Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPRERA
2024-518775-54-00Phase 4Authorised
- Sponsor
- Karolinska University Hospital
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisolone in rheumatoid arthritis (RA) (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Clinical effectiveness (primary). Planned start Oct 2024; status: authorised.
02
Drugs
prednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2024-518775-54-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518775-54-00.